Popular on Amzeal
- From Courtroom to Coinstore: Gram Trading Launches, Marking Lantah's Defiant Trademark Victory
- Generative AI University and Small Business Results Unite to Help Entrepreneurs Optimize Marketing and Growth
- Letters Of Hope ! Postal Apocalypse #LettersOfHope
- Unmissable Lease-to-Own Opportunity: Luxury Home in Rotonda West with a Thriving Airbnb Business
- New Automated Platform Expands VSA's Omnichannel Capabilities
- THINKWARE Announces Labor Day Dash Cam Specials
- DialCare Announces New Chief Information Officer
- Tobu Railway Is Operating the "Oze Night Train 23:45" On Select Dates in August, September, and October 2024!
- EVO Solar Inverters in Stock: Celebrate the 15th Anniversary with New Product Launch
- Art-Tech Rise Celebrates Success of First Hackathon with Innovative Game Demo on Ocean Cleanup
Similar on Amzeal
- CCHR Seeks Redress for Those Forcibly Held and Harmed in Behavioral Facilities
- DocVilla Introduces Best All-in-One Customizable Cloud-Based EHR Practice Management Software for Multi-Specialty and Small Practices
- Sycamore Hills Dentistry Welcomes the Yomi Robot: The Future of Dental Implant Surgery
- Cooking with Claudine Re-Launches in September with Fresh, Organic, and Gluten-Free Meal Delivery in the San Francisco Bay Area
- Dr. Seth Chambers Shares Journey to Success in Implant Dentistry on Unofficial Podcast's Summer Series: "Mind, Body, & Arches"
- Health is for EveryBODY™ Campaign Partners with Chip In™
- Melanated Cares Foundation to Host 2024 Annual Camping Retreat "Melanated Campout" Powered by Winnebago Industries Foundation
- Health is for EveryBODY™ Welcomes Ciba Health as a Sponsor
- Planned Spin-Out to Focus on Gene Therapy for Type 1 and 2 Diabetes in Parallel to Treatments for Late Stage Lung Cancer: Genprex: Stock Symbol: GNPX
- I Feel Fine coming-of-age movie set for release on National Suicide Prevention Day
The ROS1ders Issue RFA for $75K ROS1+ Cancer Innovation Award
Amzeal News/10559384
Patient-founded nonprofit seeks to stimulate innovative research to improve outcomes for patients with ROS1+ cancers.
SACRAMENTO, Calif. - Amzeal -- The ROS1ders is pleased to issue their 2024 Request for Application (RFA) to study ROS1-positive (ROS1+) cancer. The RFA is open to investigators who hold a doctorate degree and a faculty appointment at an academic or non-profit research institution anywhere in the world.
"While oral targeted therapies are approved to treat ROS1+ cancer, the drugs don't work for everyone, and they eventually stop working. We are committed to investing in research to improve patient outcomes," says Janet Freeman-Daily, MS, Engr, co-founder and president of The ROS1ders.
The ROS1+ Cancer Innovation Award aims to fund high-risk, high-reward projects focused on ROS1+ cancers. The one-year $75,000 seed grant can be used for pre-clinical, translational, or clinical research.
"Seed grants allow for the generation of initial data to support larger research endeavors," said D. Ross Camidge, MD, PhD, Professor of Medicine/Oncology at the University of Colorado and a member of The ROS1ders Scientific Advisory Board. "While some seeds fail, others grow into mighty trees - they can be the seeds of real breakthroughs."
More on Amzeal News
The award program uses a two-step application process. The deadline for a letter of intent is May 3, 2024. Those invited to submit a full application must provide it by August 4, 2024. For more information, visit https://theros1ders.org/seed-grant-program.
About the ROS1ders
Founded by patients in 2015 and incorporated in 2019, The ROS1ders is the largest global group of patients and family members living with ROS1+ cancer. It seeks to improve outcomes for all ROS1+ cancers through community, education, and research. Membership in their private Facebook group exceeds 1200 people from over 30 countries. The nonprofit is internationally recognized in the oncology and patient advocacy communities as experts in their disease. Its resources include a medically-vetted website and collaboration with international ROS1+ clinicians, researchers and industry. Please visit theros1ders.org to learn more.
More on Amzeal News
About ROS1+ Cancer
"While oral targeted therapies are approved to treat ROS1+ cancer, the drugs don't work for everyone, and they eventually stop working. We are committed to investing in research to improve patient outcomes," says Janet Freeman-Daily, MS, Engr, co-founder and president of The ROS1ders.
The ROS1+ Cancer Innovation Award aims to fund high-risk, high-reward projects focused on ROS1+ cancers. The one-year $75,000 seed grant can be used for pre-clinical, translational, or clinical research.
"Seed grants allow for the generation of initial data to support larger research endeavors," said D. Ross Camidge, MD, PhD, Professor of Medicine/Oncology at the University of Colorado and a member of The ROS1ders Scientific Advisory Board. "While some seeds fail, others grow into mighty trees - they can be the seeds of real breakthroughs."
More on Amzeal News
- Life with Lucia and Glynn: A Global Duo Spreading Joy Through Matching Shirts and Adventures
- Luxury Real Estate Agent James Edmunds lists luxury beach home in the heart of Deerfield Beach
- Sycamore Hills Dentistry Welcomes the Yomi Robot: The Future of Dental Implant Surgery
- MGN Logistics, Inc. and Arvo A.I. Ltd Forge Game-Changing Partnership to Supercharge Freight Management!
- HFES Launches Refreshed Website Design for Inclusive Collaboration and Engagement
The award program uses a two-step application process. The deadline for a letter of intent is May 3, 2024. Those invited to submit a full application must provide it by August 4, 2024. For more information, visit https://theros1ders.org/seed-grant-program.
About the ROS1ders
Founded by patients in 2015 and incorporated in 2019, The ROS1ders is the largest global group of patients and family members living with ROS1+ cancer. It seeks to improve outcomes for all ROS1+ cancers through community, education, and research. Membership in their private Facebook group exceeds 1200 people from over 30 countries. The nonprofit is internationally recognized in the oncology and patient advocacy communities as experts in their disease. Its resources include a medically-vetted website and collaboration with international ROS1+ clinicians, researchers and industry. Please visit theros1ders.org to learn more.
More on Amzeal News
- Take care of your pregnancy health with us
- The Kendall Project Accelerating AI Roadmapping Efforts Across Key Industries
- Jenni Lee Launches Kona Houses For Sale, Offering Comprehensive Real Estate Services in Kona, Hawaii and Surrounding Areas
- Cooking with Claudine Re-Launches in September with Fresh, Organic, and Gluten-Free Meal Delivery in the San Francisco Bay Area
- TalentWell Launches Next Generation of AI-powered Talent Sourcing with Automated, Personalized Videos
About ROS1+ Cancer
- ROS1+ cancer is relatively rare, occurring in just 1-2% of non-small cell lung cancer (NSCLC). The incidence is thought to be similar in other types of cancer.
- Biomarker testing for ROS1 fusions is recommended in guidelines for non-small cell lung cancer (NSCLC), but for few other cancers.
- Patients are typically younger than the average NSCLC patient, have adenocarcinoma, and have no smoking history (a smoking history should not exclude patients from biomarker testing or targeted therapies).
- Oral targeted therapies are the recommended first-line treatment for metastatic ROS1+NSCLC and have increased the survival of patients by years. However, these drugs eventually stop working due to acquired resistance. The mechanisms of resistance are not well understood.
Source: The ROS1ders, Inc.
0 Comments
Latest on Amzeal News
- BroadSource EMU Calling and Provisioning Protection (CAPP)
- SteepleMate Unveils AI-Powered Assist Tool to Revolutionize Church Management
- Women of Color STEM Conference Launches Inaugural Impact Awards
- VisualOn and Norlys Mark 10 Years of OTT Innovation, Reach Samsung Smart TV Integration Milestone
- Lineus Medical Announces a Reduction in Price for SafeBreak Vascular
- Finance Mentor: Revolutionizing Financial Coaching
- Empowering Artistry: The Fierce Feminine of ReFi Collection Debuts
- Youth Mental Health Abuse: Drugs, Sexual Assault, and Electroshock Exposed
- The Misfits Magazine Makes it Debut
- Oliver Sean's "Mama Taught Me (Dance Mix)" Featuring DJ Xquizit Hits #1 in Multiple Countries Within 24 Hours of Release
- Epic Fit Fest Celebrates Diversity, Wellness, and Community in Grand Prairie, Texas
- New Jersey Pediatric Neuroscience Institute Opens State-of-the-Art Pediatric Neuroscience Center in Hamilton, NJ
- THINKWARE Announces Labor Day Dash Cam Specials
- Black Women Talk Tech's 'Roadmap to Billions' Conference Debuts in Toronto – Empowering Black Women in Tech
- Kaplan Morrell Named Exclusive Workers' Compensation Firm for Greeley Police Officers Association
- Hoffman Homes Unveils New Brand
- Hanover Area YMCA Academy of Early Learning Awarded ECHO Innovation Grant
- An Officer and Gentlewoman, LLC Hired as Public Relations Partner for The Annual Atlanta Fashion and Polo Classic
- Point Source Audio Partners w/ Industry Leaders to Explore Theatre Miking Techniques in New Webinar
- EXPOSE Summer Youth Program Provides a Host of Benefits to High School Students